{"id":217,"date":"2025-09-17T17:22:00","date_gmt":"2025-09-17T11:52:00","guid":{"rendered":"https:\/\/www.najao.com\/learn\/?p=217"},"modified":"2026-01-26T04:39:29","modified_gmt":"2026-01-25T23:09:29","slug":"immunotherapy","status":"publish","type":"post","link":"https:\/\/www.najao.com\/learn\/immunotherapy\/","title":{"rendered":"Immunotherapy: Harnessing the Body’s Own Power to Fight Disease"},"content":{"rendered":"\n

In modern times, immunotherapy has revolutionized medical treatment and is being used to address a wide spectrum of diseases, offering new hope and effective treatment methodologies. Unlike traditional treatment methods that directly interact with the disease-causing agents, immunotherapy alters one\u2019s own immune system to empower the body’s natural defense<\/a> mechanisms for health restoration. Immunotherapy does this either by boosting an inadequate immune response or by suppressing an overactive or misdirected one1<\/sup><\/strong>.<\/p>\n\n\n\n

Immunotherapy relies on a complex network of cells, tissues, and organs that defend the body against foreign molecules and internal threats.  This network includes key players such as T-cells, B-cells, macrophages, natural killer cells, and antibodies. They all work in a synchronized manner to identify and eliminate anything considered “non-self” or harmful. Normally, the body\u2019s immune system performs exceptionally well to detect, fight off infections, and even destroy precancerous cells. When the immune system either becomes too weak to recognize a threat or mistakenly attacks healthy tissues, it can cause severe abnormalities or diseases. Immunotherapy aims to correct these dysfunctions.<\/p>\n\n\n\n

<\/a>Diverse Applications<\/h2>\n\n\n\n

Due to its significant impact on cancer <\/a>treatments, immunotherapy has garnered significant attention on a much broader medical landscape.<\/p>\n\n\n\n

<\/a>Immunotherapy for cancer<\/h3>\n\n\n\n

In cancer, the body\u2019s immune system often fails to recognize and thus effectively eliminate cancer cells. This allows them to evade the surveillance of the immune system. Cancer immunotherapy aims to overcome these evasive tactics, empowering the immune system to identify, target, and destroy malignant cells.<\/p>\n\n\n\n

Immune checkpoint inhibitors<\/h4>\n\n\n\n

Immune checkpoint inhibitors<\/a> target the immune cells, particularly T-cells, helping them to effectively recognize and attack cancerous cells2<\/sup><\/strong>. They work by blocking expressions of proteins like PD-1, PD-L1, or CTLA-4. These therapies have revolutionized the treatment of melanoma, lung cancer, kidney cancer, and other similar conditions.<\/p>\n\n\n\n

CAR T-Cell Therapy<\/h4>\n\n\n\n

CAR T-Cell Therapy<\/a> involves genetically engineered T cells (patients\u2019 own T cells) expressing Chimeric Antigen Receptors (CARs) that specifically target cancer cells3<\/sup><\/strong>. This has shown remarkable success in certain blood cancers like aggressive lymphomas and leukemias.<\/p>\n\n\n\n

Therapeutic monoclonal antibodies<\/h4>\n\n\n\n

These are engineered antibodies that can directly target cancer cells4<\/sup><\/strong>. Their mechanism of action involves blocking growth signals or marking them for destruction by other immune cells.<\/p>\n\n\n\n

Cancer vaccines<\/h4>\n\n\n\n

These aim to stimulate immune response. While preventative vaccines (like the HPV vaccine) are highly successful, therapeutic cancer vaccines for existing cancers are an active area of research5<\/sup>.<\/p>\n\n\n\n

Oncolytic viruses<\/h4>\n\n\n\n

Oncolytic viruses<\/a> are genetically modified viruses that selectively infect and destroy cancer cells6<\/sup><\/strong>. Simultaneously they also stimulate an immune response against the tumor6<\/sup>.<\/p>\n\n\n\n

<\/a>Immunotherapy for autoimmune diseases<\/h3>\n\n\n\n

In autoimmune diseases, the immune system mistakenly identifies the body’s own healthy tissues as foreign objects and initiates an attack. Immunotherapy in this context focuses on suppressing the immune system to prevent this self-destruction. Some of the treatment methods include:<\/p>\n\n\n\n

Targeted Biologics (Monoclonal Antibodies)<\/h4>\n\n\n\n

In conditions such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, and multiple sclerosis, treatment strategies involve using targeted biologics or monoclonal antibodies. These highly specific drugs block key inflammatory molecules (cytokines like TNF-alpha, IL-6, IL-17) or deplete specific immune cell populations (like B-cells), thereby reducing inflammation and tissue damage7<\/sup><\/strong>.<\/p>\n\n\n\n

Immunosuppressants<\/h4>\n\n\n\n

These drugs reduce or suppress the immune system8<\/sup><\/strong>. While older, broader immunosuppressants exist, newer immunotherapies offer more targeted approaches to modulate the immune response. Examples include corticosteroids, calcineurin inhibitors, etc.<\/p>\n\n\n\n

Emerging cell therapies<\/h4>\n\n\n\n

This involves introducing living cells into a patient’s body to replace, repair, or enhance the function of diseased or damaged tissues, or to modulate the immune system. Research is exploring the use of regulatory T-cells to induce immune tolerance and halt autoimmune attacks9<\/sup>.<\/p>\n\n\n\n

<\/a>Immunotherapy for allergic diseases<\/h3>\n\n\n\n

Allergies occur when our immune system reacts to otherwise harmless substances (allergens). Immunotherapy aims to desensitize the body to these allergens, thus reducing the severity of allergic reactions.<\/p>\n\n\n\n

Allergen immunotherapy<\/h4>\n\n\n\n

This involves gradual exposure to increasing doses of the allergen, which builds the immune system’s tolerance over time and shifts its response away from the problematic IgE antibodies10<\/sup><\/strong>. This is effective for allergic rhinitis (hay fever), allergic asthma, and insect sting allergies.<\/p>\n\n\n\n

Monoclonal antibodies<\/h4>\n\n\n\n

Some antibodies are designed to block key mediators of allergic reactions, such as IgE, providing relief for severe asthma and chronic hives11<\/sup>.<\/p>\n\n\n\n

<\/a>Immunotherapy for infectious diseases<\/h3>\n\n\n\n

Immunotherapy also plays a crucial role in preventing and treating infectious diseases by enhancing the body’s natural defenses against pathogens.<\/p>\n\n\n\n

Vaccines (Prophylactic)<\/h4>\n\n\n\n

One of the oldest and most effective treatment methods involves the use of vaccines. They prime the immune system to recognize and remember specific pathogens before exposure, preventing infection12<\/sup><\/strong>. Examples include measles, polio, influenza, and COVID-19 vaccines.<\/p>\n\n\n\n

Therapeutic vaccines<\/h4>\n\n\n\n

For chronic infections like HIV or hepatitis B\/C, research is ongoing to develop vaccines that can boost the immune system to recognize and clear existing infections13<\/sup><\/strong>.<\/p>\n\n\n\n

Monoclonal antibodies (passive immunization)<\/h4>\n\n\n\n

An immediate, temporary immunity can be achieved by directly supplying antibodies to neutralize pathogens or their toxins. These are utilized in the treatment of respiratory syncytial virus in infants or certain severe viral infections14<\/sup><\/strong>.<\/p>\n\n\n\n

Adoptive cell therapies<\/h4>\n\n\n\n

Transferring immune cells with specific anti-pathogen activity can be used to treat severe infections in immunocompromised patients, such as cytomegalovirus infection in transplant recipients15<\/sup><\/strong>.<\/p>\n\n\n\n

Advantages and challenges<\/h2>\n\n\n\n

Immunotherapy has the advantage of targeting disease-specific pathways with less collateral damage to healthy tissues. It can lead to durable and long-lasting responses, sometimes even after treatment cessation, due to the establishment of immune memory16<\/sup><\/strong>. Such specificity of immunotherapy has opened doors as novel treatment options for diseases previously lacking effective therapies.<\/p>\n\n\n\n

However, immunotherapy has challenges too.<\/p>\n\n\n\n